Ensuring viral safety in oncolytic virus manufacturing can be particularly complex when neutralizing antibodies interfere with traditional biosafety assays.
In this session, we will explore how GMP NGS enables accurate detection of adventitious agents and supports risk mitigation when antibodies threaten viral safety assessment. You’ll gain insight into regulatory expectations, case studies, and how integrating NGS-based biosafety into your workflow can de-risk development and accelerate timelines.
Key takeaways:
• Addressing antibody neutralization in oncolytic virus GMP manufacturing
• Enhancing biosafety with validated NGS approaches
• Real-world applications and regulatory insights
Secure your place today and explore how GMP NGS empowers oncolytic virus manufacturers to ensure viral safety and, speed up timelines.
Presented by
Colette Côté, PhD U.S. General Manager
and Chief Scientific
and Portfolio Officer
PathoQuest
Colette Côté joined PathoQuest as US General Manager and Chief Scientific and Portfolio Officer in March 2021. Prior to joining PathoQuest, Colette was the Director and Head of NGS R&D Testing Services at MilliporeSigma. Over the past 17 years, Colette has used her expertise and long history of innovating, developing, and applying tailored NGS-based assays to the biosafety testing space with a goal to expand and grow NGS far beyond its early applications, with a view towards the future.
Followed by a live Question and Answer Session
Sponsored by
PathoQuest is a global CRO providing Next Generation Sequencing (NGS)-based Quality Control testing through its iDTECT® assay platform. This platform enables faster, safer and animal free testing for the release of biotherapies to patients. We offer GMP-validated assays for viral safety and genetic characterization of raw materials, cell and gene therapies, monoclonal antibodies and vaccines. Our laboratories in Paris, France, and Wayne, PA, USA, provide global and reliable support to accelerate the availability of biologics.
Learn more: https://pathoquest.com/
